Two independent studies show that ephrin-B2 controls the internalization and signaling of two types of vascular endothelial growth factor (VEGF) receptors—thereby regulating VEGF-induced ...

In response, the industry has begun a new round of layout in the obesity treatment sector, with several pharmaceutical companies focusing on other new therapeutic targets, such as the Activin ...